InvestorsHub Logo
Followers 54
Posts 3381
Boards Moderated 0
Alias Born 10/26/2013

Re: Ville post# 2154

Thursday, 05/03/2018 4:13:14 PM

Thursday, May 03, 2018 4:13:14 PM

Post# of 3283
Ville, good news on Rolontis abstract at ASCO! From the 1st Q Financial Results PR

ROLONTIS® (eflapegrastim)Phase 3 data abstract to be released by American Society of Clinical Oncology (ASCO) followed by an oral presentation at Multinational Association of Supportive Care in Cancer (MASCC) in June 2018.